Withdrawn-product notification: questions and answers
This page lists questions relating to marketing cessation, marketing suspension and withdrawals of medicinal productsfrom the market and of marketing authorisations in the context of the implementation of Directive 2012/26/EU and Regulation (EU) No 1027/2012 amending the pharmaceutical legislation with respect to pharmacovigilance.
Click on this link for more information.
